Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



Postdoctoral Fellowship Awards

2019 (Cycle 30)
miR-200 MicroRNAs in Lung cancer metastasis 2019 (Cycle 30) $191,832
University of California, Berkeley Cancer

Maternal inhaled nicotine enhances endothelial nitric oxide synthase uncoupling leading to a hypertensive phenotype in offspring 2019 (Cycle 30) $187,831
Loma Linda University Cardiovascular and Cerebrovascular Disease

Targeting the unique metabolic vulnerabilities of lung cancer 2019 (Cycle 30) $199,872
University of California, San Diego Cancer

Effect of nicotine on the cardiac aging process 2019 (Cycle 30) $191,832
University of California, San Diego Cardiovascular and Cerebrovascular Disease

Effects of Prenatal Nicotine and THC on Dopaminergic Function and Nicotine Intake During Adolescence 2019 (Cycle 30) $199,872
University of California, Irvine Neuroscience of Nicotine Addiction and Treatment

Stem cell signals in the initiation and progression of lung cancer 2019 (Cycle 30) $137,550
University of California, San Diego Cancer

Effects of long-term nicotine exposure on stem cell therapy 2019 (Cycle 30) $207,300
Stanford University Cardiovascular and Cerebrovascular Disease

Multilayer investigation of resistance mechanisms to WEE1 inhibition in Small Cell Lung Cancer 2019 (Cycle 30) $207,300
Stanford University Cancer

Targeting pH Homeostasis as a Therapeutic Approach for Pancreatic Cancer 2019 (Cycle 30) $195,450
Sanford Burnham Prebys Medical Discovery Institute Cancer

Defining the mechanism of dynamic matrix stiffening-driven lung cancer metastasis 2019 (Cycle 30) $193,320
University of California, San Diego Cancer

A Human iPSC-based Platform to Unravel the Role of Nicotine in the Pathogenesis of Abdominal Aortic Aneurysms 2019 (Cycle 30) $178,440
Stanford University Cardiovascular and Cerebrovascular Disease

The effect of combustible cigarettes and electronic cigarettes on oral Candida pathogenesis 2019 (Cycle 30) $187,116
University of California, Los Angeles Oral Disease and Dental Health

2019 (Cycle 29)
Constructing a Lung Cancer Map of Drug Resistance States with Single-Cell Analysis 2019 (Cycle 29) $138,450
Stanford University Cancer

Everyday smoking contexts and practices of bisexual young adults 2019 (Cycle 29) $135,392
University of California, San Francisco Tobacco-Use Prevention and Cessation

Implications of stress-induced LPAR4 expression in lung and pancreatic cancers 2019 (Cycle 29) $180,996
University of California, San Diego Cancer

Effects of Smoking on Hematopoietic Stem Cell Dysfunction and Hematologic Cancers 2019 (Cycle 29) $122,958
University of California, Irvine Cancer

Epigenetic mechanisms in the inflammatory oral lesion of smokers 2019 (Cycle 29) $198,036
University of California, Los Angeles Oral Disease and Dental Health

Effects of cigarette smoke on inflammasome activation in oral cells 2019 (Cycle 29) $176,616
University of the Pacific Oral Disease and Dental Health

Notch3 in Human Lung Adenocarcinoma Pathogenesis and Heterogeneity 2019 (Cycle 29) $176,982
University of California, San Francisco Cancer

Functions of caspase-8 mutations in development of head and neck cancer and anti-tumor immunity 2019 (Cycle 29) $247,872
University of California, San Francisco Oral Disease and Dental Health

At the Intersection of social inequity: Tobacco use disparities among diverse LGBTQ adolescents 2019 (Cycle 29) $213,864
San Diego State University Research Foundation Tobacco-Use Prevention and Cessation

Analysis of bladder cancer precursor formation as a basis for early therapeutic intervention 2019 (Cycle 29) $193,320
Stanford University Cancer

Investigating the Roles of Stromal AR in Prostate Cancer Progression 2019 (Cycle 29) $203,280
University of California, Santa Cruz Cancer

Modeling Smoking Induced Cardiac Dysfunction in 3D Microtissues 2019 (Cycle 29) $128,086
Stanford University Cardiovascular and Cerebrovascular Disease

Targeting nuclear receptors for the treatment of Pancreatic cancer 2019 (Cycle 29) $180,996
University of California, San Diego Cancer

2019 (Cycle 28)
Flavored tobacco initiation among youth and young adults 2019 (Cycle 28) $62,243
University of California, San Francisco Tobacco-Use Prevention and Cessation

Defining the Role of Hedgehog Signaling in Emphysema 2019 (Cycle 28) $180,996
University of California, San Francisco Pulmonary Disease

Protein Engineering Aids Chimeric Antigen Receptor Design 2019 (Cycle 28) $173,676
Beckman Research Institute of the City of Hope Cancer

The Influence of Social Media on Adolescents' E-Cig Use 2019 (Cycle 28) $117,143
Stanford University Tobacco-Use Prevention and Cessation

HER3-biased Sec61 modulators for treatment of cancers 2019 (Cycle 28) $173,676
University of California, San Francisco Cancer

Brd4 function in cardiac lineage commitment & morphogenesis 2019 (Cycle 28) $136,538
University of California, San Francisco Cardiovascular and Cerebrovascular Disease

Large-scale analysis of tumor suppressors in lung cancer 2019 (Cycle 28) $173,676
Stanford University Cancer

The Influence of Social Media on Adolescents' E-Cig Use 2019 (Cycle 28) $60,503
University of California, San Francisco Tobacco-Use Prevention and Cessation

Inflammatory State of Macrophages and COPD Exacerbation 2019 (Cycle 28) $177,972
University of California, San Francisco Pulmonary Disease

Exosome Release and the Immune Response to Exercise in COPD 2019 (Cycle 28) $193,320
LA Biomedical Research Institute at Harbor-UCLA Medical Center Pulmonary Disease

2018 (Cycle 27)
Targeting Macrophages in the Cancer Stem Cell Niche to Beat Chemoresistance 2018 (Cycle 27) $222,407
University of California, Los Angeles Cancer

The Action of Nicotine and Nicotine Cessation Drugs Inside Cells 2018 (Cycle 27) $182,184
California Institute of Technology Neuroscience of Nicotine Addiction and Treatment

Studies on SWI/SNF in 3D chromatin structure with viral epis 2018 (Cycle 27) $212,207
University of California, Davis Cancer

Shear Stress : a Master Regulator of the Endothelial Chromatin 2018 (Cycle 27) $223,884
Stanford University Cardiovascular and Cerebrovascular Disease

Role of exosomes in rescuing Xerostomia in head and neck cancer 2018 (Cycle 27) $200,297
Stanford University Oral Disease and Dental Health

E-cigarette smoking-induced cardiac injury in East Asian AL 2018 (Cycle 27) $209,484
Stanford University Not specified

Genetic dissection of oncogenic Kras signaling in lung cancer 2018 (Cycle 27) $184,512
Stanford University Cancer

2017 (Cycle 26)
Analysis of Circulating Tumor RNA for Early Detection of Lung Cancer 2017 (Cycle 26) $118,800
Stanford University Early Diagnosis of Tobacco-Related Cancer

Predilection of CHRNA5 SNP to smoking-related cardiotoxicity 2017 (Cycle 26) $118,800
Stanford University Socio-cultural, Behavioral and Psychological

ELECTROCHEMICAL ANALYSIS of DNMT1 and miRNA AS BIOMARKERS OF LUNG CANCER 2017 (Cycle 26) $118,800
California Institute of Technology Early Diagnosis of Tobacco-Related Cancer

2016 (Cycle 25)
High-throughput systems to dissect Snail-driven malignancy 2016 (Cycle 25) $69,879
University of California, Los Angeles Early Diagnosis of Tobacco-Related Cancer

Molecular mechanisms of smoking-associated lung cancer 2016 (Cycle 25) $118,449
Salk Institute for Biological Studies Early Diagnosis of Tobacco-Related Cancer

Lateral septum circuitry underlying vulnerability to nicotine consumption 2016 (Cycle 25) $118,800
University of California, San Diego Neuroscience of Nicotine Addiction and Treatment

Smartphone-based smoking cessation with young adults 2016 (Cycle 25) $63,073
University of California, San Francisco Tobacco-Use Prevention and Cessation

TERT expression and its involvement in pancreatic regeneration and PDAC 2016 (Cycle 25) $118,800
Stanford University Early Diagnosis of Tobacco-Related Cancer

miR-34/449 miRNAs in airway multiciliated cells 2016 (Cycle 25) $9,551
University of California, Berkeley Pulmonary Disease

Differential softening of smokers in California 2016 (Cycle 25) $98,339
University of California, San Francisco Tobacco-Related Health Disparities

A Differential Approach to Investigate Head and Neck Cancer 2016 (Cycle 25) $118,800
J. David Gladstone Institutes Early Diagnosis/Pathogenesis

2015 (Cycle 24)
Molecular and Cellular Phenotyping of Second Hand Smoke-Related Asthma 2015 (Cycle 24) $47,769
Stanford University Environmental Exposure/Toxicology

ROLE OF TOBACCO-RELATED TOXICANTS IN CARDIOVASCULAR DISEASE 2015 (Cycle 24) $145,800
University of California, San Diego Early Diagnosis/Pathogenesis

Cardiotoxicity Study of Tobacco Smoking Using hiPSC-CMs 2015 (Cycle 24) $145,800
Stanford University Early Diagnosis/Pathogenesis

2014 (Cycle 23)
Effects of varenicline in heavy drinking smokers 2014 (Cycle 23) $118,870
University of California, Los Angeles Disparities /Prevention/ Cessation/ Nicotine Dependence

Detection of tumor DNA in plasma: definitive early diagnosis 2014 (Cycle 23) $25,104
Stanford University Early Diagnosis/Pathogenesis

Health Disparities: Tobacco Media and LGBT Tobacco Use 2014 (Cycle 23) $143,935
University of California, San Diego Disparities /Prevention/ Cessation/ Nicotine Dependence

Novel modulation of AMPA receptor activity by ly-6 proteins 2014 (Cycle 23) $40,668
University of California, San Diego Environmental Exposure/Toxicology

Targeting phospho-MARCKS in smoke-mediated lung cancer 2014 (Cycle 23) $91,436
University of California, Davis Early Diagnosis/Pathogenesis

2013 (Cycle 22)
Exploring media to reduce LGBT tobacco use 2013 (Cycle 22) $32,343
Stanford University Disparities /Prevention/ Cessation/ Nicotine Dependence

Targeting Smyd3 methyltansferase for lung cancer therapy 2013 (Cycle 22) $101,422
Stanford University Early Diagnosis/Pathogenesis

Adoption and Implementation of Campus Tobacco-free Policies 2013 (Cycle 22) $41,670
University of California, San Francisco Industry Influence/Policy

Menstrual cycle effects on response inhibition in smoking 2013 (Cycle 22) $96,661
University of Southern California Disparities /Prevention/ Cessation/ Nicotine Dependence

Nicotine Dependence, Metabolism and Smoke Intake in Blacks 2013 (Cycle 22) $87,835
University of California, San Francisco Disparities /Prevention/ Cessation/ Nicotine Dependence

The role of VTA glutamate afferents in nicotine addiction 2013 (Cycle 22) $145,681
University of California, San Diego Disparities /Prevention/ Cessation/ Nicotine Dependence

Chromatin remodellers Brg1 and Baf60c in heart development 2013 (Cycle 22) $145,800
J. David Gladstone Institutes Early Diagnosis/Pathogenesis

2012 (Cycle 21)
Nicotine replacement therapy in pregnancy: friend or foe? 2012 (Cycle 21) $98,506
University of California, San Diego Disparities /Prevention/ Cessation/ Nicotine Dependence

Proteomic Assessment of Heavy Metal Mixture Exposure 2012 (Cycle 21) $45,000
University of California, Riverside Environmental Exposure/Toxicology

Metabolic stress & cell survival in lung cancer 2012 (Cycle 21) $89,208
The Burnham Institute for Medical Research Early Diagnosis/Pathogenesis

NOVEL nAChR MODULATORS FOR TREATING NICOTINE ADDICTION 2012 (Cycle 21) $107,727
University of California, San Diego Disparities /Prevention/ Cessation/ Nicotine Dependence

NOVEL nAChR MODULATORS FOR TREATING NICOTINE ADDICTION 2012 (Cycle 21) $27,273
Scripps Research Institute Disparities /Prevention/ Cessation/ Nicotine Dependence

Delivering Smoking Cessation to Young Adults in Bars 2012 (Cycle 21) $84,993
University of California, San Francisco Disparities /Prevention/ Cessation/ Nicotine Dependence

Effect of mGlu7 receptor manipulation on actions of nicotine 2012 (Cycle 21) $89,777
University of California, San Diego Disparities /Prevention/ Cessation/ Nicotine Dependence

Alpha4beta2 nAChR upregulation in the perforant pathway 2012 (Cycle 21) $26,898
California Institute of Technology Disparities /Prevention/ Cessation/ Nicotine Dependence

Novel biomarkers and chemoprevention approaches for SCLC 2012 (Cycle 21) $127,052
Stanford University Early Diagnosis/Pathogenesis

2011 (Cycle 20)
Mapping the EphA Receptor Landscape in Lung Cancer 2011 (Cycle 20) $98,299
The Burnham Institute for Medical Research Cancer

The Role of Alpha2 nAChR Subtypes in Nicotine Withdrawal 2011 (Cycle 20) $135,000
University of California, Los Angeles Nicotine Dependence

Mechanisms of ephrin-B2 signaling mediating vasodilation 2011 (Cycle 20) $131,921
University of California, San Francisco Cardiovascular Disease

Gene-modified Stromal Cell Therapy for Lung Cancer 2011 (Cycle 20) $60,498
University of California, Los Angeles Cancer

Cigarette smoke and lung injury: mechanism of nSMase2 action 2011 (Cycle 20) $117,255
University of California, Davis Pulmonary Disease

Identification of Harm Reduction Sidestream Smoke Toxicants 2011 (Cycle 20) $135,000
University of California, Riverside General Biomedical Science

Delineating mechanisms of endothelial cytoprotection by APC 2011 (Cycle 20) $65,805
University of California, San Diego Cardiovascular Disease

Epigenetic effects of cigarette smoke on the infant airway 2011 (Cycle 20) $82,569
University of California, Davis Pulmonary Disease

International Health Policy and Tobacco Control in CA 2011 (Cycle 20) $84,927
University of California, San Francisco Public Health, Public Policy, and Economics

Activation of DDAH for the Treatment of Atherosclerosis 2011 (Cycle 20) $87,350
Stanford University Cardiovascular Disease

Notch mediated mechanisms of mammalian cerebral angiogenesis 2011 (Cycle 20) $104,396
University of California, San Francisco Cardiovascular Disease

2010 (Cycle 19)
Switching off a lung cancer oncogene using small molecules 2010 (Cycle 19) $135,000
University of California, San Francisco Cancer

Regulation of APC-mediated PAR1 signaling 2010 (Cycle 19) $135,000
University of California, San Diego Cardiovascular Disease

Enhancing Validity of a South Asian Tobacco Survey Module 2010 (Cycle 19) $89,999
University of California, San Francisco Tobacco-Use Prevention and Cessation

Reversible Covalent Kinase Inhibitors to Combat Metastasis 2010 (Cycle 19) $135,000
University of California, San Francisco Cancer

Oncogenic Activation Mechanisms of Phosphoinositol-3-Kinase 2010 (Cycle 19) $135,000
University of California, San Francisco Cancer

O-GlcNAc Glycosylation in Lung Cancer 2010 (Cycle 19) $111,397
California Institute of Technology General Biomedical Science

Nicotinic Control of Glutamate Synapse Formation 2010 (Cycle 19) $135,000
University of California, San Diego Nicotine Dependence

Smoking-related lung repair and early stage lung cancer 2010 (Cycle 19) $135,000
University of California, Los Angeles Cancer

Inhibiting lung cancer with DNA-binding polyamides 2010 (Cycle 19) $44,500
California Institute of Technology Cancer

Cessation and Environmental Smoking among Korean Americans 2010 (Cycle 19) $161,060
University of Southern California Tobacco-Use Prevention and Cessation

AMPA Receptors and Extinction of Nicotine-Seeking Behavior 2010 (Cycle 19) $135,000
University of California, San Diego Nicotine Dependence

2009 (Cycle 18)
Protein networks for nicotinic acetylcholine receptors 2009 (Cycle 18) $134,878
University of California, San Diego Nicotine Dependence

Harnessing the immune system to fight lung cancer 2009 (Cycle 18) $117,637
University of California, Los Angeles Cancer

Dose dependent effects of passive smoke on vascular function 2009 (Cycle 18) $41,588
University of California, San Francisco Cardiovascular Disease

Patterns of Tobacco and Marijuana Use Among Young Adults 2009 (Cycle 18) $135,000
University of California, San Francisco Epidemiology

Innate Immune Response to Head and Neck Cancer Stem Cells 2009 (Cycle 18) $134,999
Stanford University Cancer

Evaluation of GABA in impulsivity and nicotine dependence 2009 (Cycle 18) $97,458
University of California, San Diego Nicotine Dependence

Role of nicotine and nAChRs in L-dopa-induced dyskinesias. 2009 (Cycle 18) $87,963
SRI International Public Health, Public Policy, and Economics

Acquired apoptotic resistance in 3D lung cancer spheroids 2009 (Cycle 18) $135,000
University of California, San Francisco Cancer

Migrating cancer stem cells & early cancer development 2009 (Cycle 18) $90,000
University of California, Los Angeles Cancer

Targeting vascular lesions in hypercholesterolemic zebrafish 2009 (Cycle 18) $134,500
University of California, San Diego Cardiovascular Disease

Control of cellular self-digestion in lung tumorigenesis 2009 (Cycle 18) $135,000
The Burnham Institute for Medical Research Cancer

Subcellular basis of nicotine-induced receptor upregulation 2009 (Cycle 18) $135,000
California Institute of Technology Nicotine Dependence

Un-cooling Smoking Using Social Identity Theory 2009 (Cycle 18) $90,000
University of Southern California Tobacco-Use Prevention and Cessation

Pathological Angiogenesis and Nicotine: Intracellular Calcium 2009 (Cycle 18) $135,000
Stanford University Cardiovascular Disease

The role of Wilm's tumor gene 1 in lung cancer 2009 (Cycle 18) $135,000
Stanford University Cancer

Reactive oxygen species in fresh and aging SHS particles 2009 (Cycle 18) $132,137
Lawrence Berkeley National Laboratory General Biomedical Science

2008 (Cycle 17)
Targeted Imaging and Therapy of Lung Cancer 2008 (Cycle 17) $72,144
Stanford University Cancer

16S rRNA PhyloChip Analysis of Bacterial Communities in COPD 2008 (Cycle 17) $75,000
University of California, San Francisco Pulmonary Disease

Mechanisms of Tumor Suppressor in Lung Cancer Initiation 2008 (Cycle 17) $75,000
University of California, Davis Cancer

Nicotinic Regulation of GABAergic Inhibition/Excitation 2008 (Cycle 17) $75,000
University of California, San Diego Nicotine Dependence

Role of lineage-specific oncogene TITF1 in lung cancer 2008 (Cycle 17) $74,500
Stanford University Cancer

Allosteric Protein Kinase Modulators via Disulfide Trapping 2008 (Cycle 17) $75,000
University of California, San Francisco General Biomedical Science

Genomic Assay to Identify Targets of Anticancer Therapeutics 2008 (Cycle 17) $70,076
Stanford University Cancer

2007 (Cycle 16)
Alpha4* Nicotinic Receptor in Dopaminergic System 2007 (Cycle 16) $75,000
California Institute of Technology Nicotine Dependence

Targeting anti-apoptotic Bcl-2 family members in lung cancer 2007 (Cycle 16) $75,000
The Burnham Institute for Medical Research Cancer

Synthesis of Apoptotic Spirooxindoles 2007 (Cycle 16) $75,000
Beckman Research Institute of the City of Hope General Biomedical Science

Inhibition of MYC-activated gene expression by polyamides 2007 (Cycle 16) $71,330
California Institute of Technology General Biomedical Science

The Smoking Abstinence Questionnaire 2007 (Cycle 16) $74,997
University of California, San Francisco Tobacco-Use Prevention and Cessation

Role of inflammation in lung carcinoma neovascularization 2007 (Cycle 16) $75,000
University of California, San Diego Cancer

Mechanism of DNA break repair in germline cells 2007 (Cycle 16) $75,000
University of California, Davis Cancer

Oxygen Transport Following Lung Transplantation in COPD 2007 (Cycle 16) $74,500
University of California, San Diego Pulmonary Disease

Impact of Positive Mood on Self-Control Depletion in Smoking 2007 (Cycle 16) $63,340
University of California, San Francisco Tobacco-Use Prevention and Cessation

Effect of Oxidation on Rate of ApoA-I - HDL Exchange 2007 (Cycle 16) $75,000
Children's Hospital Oakland Research Institute Cardiovascular Disease

Novel Cationic Polymers for RNAi Delivery in NSCLC Treatment 2007 (Cycle 16) $34,141
University of California, Irvine Cancer

2006 (Cycle 15)
Pathways of how socioeconomic context affects teen smoking 2006 (Cycle 15) $75,000
University of California, Los Angeles Public Health, Public Policy, and Economics

Nicotine Receptors: Role in Nicotine Addiction 2006 (Cycle 15) $20,748
California Institute of Technology Nicotine Dependence

Effect of Sidestream Tobacco Smoke on Parkin Null Mice 2006 (Cycle 15) $48,256
University of California, Los Angeles Cancer

The molecular basis of apoE and LDL receptor interaction 2006 (Cycle 15) $75,000
Children's Hospital Oakland Research Institute Cardiovascular Disease

Effect of tobacco toxins on human germ cell development 2006 (Cycle 15) $33,290
University of California, San Francisco General Biomedical Science

How omega-3 fatty acids prevent or slow cancer 2006 (Cycle 15) $74,808
The Burnham Institute for Medical Research Cancer

Effect of tobacco toxins on human germ cell development 2006 (Cycle 15) $40,204
Stanford University General Biomedical Science

Nicotine recp mediated dopamine release and chronic nicotine 2006 (Cycle 15) $75,000
The Parkinson's Institute General Biomedical Science

Development of Fluorescent Probes for Sensing DNA Mismatches 2006 (Cycle 15) $65,369
California Institute of Technology General Biomedical Science

How smoke induces lung damage via oxidative stress 2006 (Cycle 15) $75,000
University of California, Davis Pulmonary Disease

2005 (Cycle 14)
Role of GL12 in oral mucosa maintenance and carcinogenesis 2005 (Cycle 14) $73,485
University of California, San Francisco Cancer

Marketing low-tar cigarettes and new harm-reduced products 2005 (Cycle 14) $74,500
University of California, San Francisco Public Health, Public Policy, and Economics

Integrin receptors and heart disease 2005 (Cycle 14) $35,323
University of California, San Diego Cardiovascular Disease

Bupropion and nicotine dependence: behavior & neurochemisty 2005 (Cycle 14) $37,500
Scripps Research Institute Nicotine Dependence

Effects of nicotine on hematopoietic stem cell migration 2005 (Cycle 14) $74,500
La Jolla Institute for Molecular Medicine General Biomedical Science

Chemical synthesis of communesin B, a novel antineoplastic 2005 (Cycle 14) $74,403
California Institute of Technology General Biomedical Science

Bupropion and nicotine dependence: behavior & neurochemisty 2005 (Cycle 14) $37,000
University of California, San Diego Nicotine Dependence

Nicotine's effects on uterine artery contractillity 2005 (Cycle 14) $73,878
Loma Linda University Nicotine Dependence

Role of p53-regulated sestrin genes in lung cancer 2005 (Cycle 14) $73,500
University of California, San Diego Cancer

Effect of PDGF inhibition on angiogenesis in lung cancer 2005 (Cycle 14) $74,500
University of California, San Francisco Cancer

2004 (Cycle 13)
Nicotine effects on gene expression and metaplasticity 2004 (Cycle 13) $74,500
Stanford University Nicotine Dependence

Regulation of nicotinic signaling 2004 (Cycle 13) $20,499
University of California, San Diego Nicotine Dependence

Chronic CO exposure impairs the developing auditory system 2004 (Cycle 13) $75,000
University of California, Los Angeles General Biomedical Science

Nicotinic receptors at GABAergic synapses in the hippocampus 2004 (Cycle 13) $75,000
University of California, San Diego Nicotine Dependence

Regulation of epithelial cell polarity and lung disease 2004 (Cycle 13) $75,000
University of California, San Francisco Pulmonary Disease

The role of platelets in atherogenesis in the mouse 2004 (Cycle 13) $34,769
University of California, San Francisco Cardiovascular Disease

Tobacco oxidants, EGF receptor stability, and lung disease 2004 (Cycle 13) $75,000
University of California, Davis Pulmonary Disease

2003 (Cycle 12)
COX-2-dependent modulation of survivin in lung cancer 2003 (Cycle 12) $69,500
University of California, Los Angeles Cancer

IRAK-1 & active TGF-beta: Counter-regulators in emphysema? 2003 (Cycle 12) $69,000
University of California, San Francisco Pulmonary Disease

Tobacco industry analysis of secondhand smoke 2003 (Cycle 12) $70,000
University of California, San Francisco Public Health, Public Policy, and Economics

Triglyceride metabolism: Genetics, smoking and heart disease 2003 (Cycle 12) $75,438
J. David Gladstone Institutes Cardiovascular Disease

Structure of CYP2A6: the principal nicotine oxidase 2003 (Cycle 12) $75,060
Scripps Research Institute General Biomedical Science

Regulatory genes of nicotine adaptation in C.elegans 2003 (Cycle 12) $70,000
University of California, San Diego Nicotine Dependence

Second Hand Smoke: Latino asthmatic children 2003 (Cycle 12) $75,506
San Diego State University Research Foundation Epidemiology

Mechanism of TGF-a shedding in lung cancer development 2003 (Cycle 12) $69,600
University of California, San Francisco Cancer

Focal adhesion kinase regulation of Cox-2 in lung cancer 2003 (Cycle 12) $74,520
Scripps Research Institute Cancer

Individual and gender differences in nicotine sensitivity 2003 (Cycle 12) $69,495
University of California, Irvine Nicotine Dependence

Tobacco use, home policy, and life events in at-risk women 2003 (Cycle 12) $75,386
San Diego State University Research Foundation Epidemiology

2002 (Cycle 11)
Multibehavioral changes for disease prevention among smokers 2002 (Cycle 11) $69,824
University of California, San Francisco Epidemiology

Nicotinic receptors on hippocampal neurons 2002 (Cycle 11) $69,940
University of California, San Diego Nicotine Dependence

Tobacco carcinogens influence Ah-receptor function 2002 (Cycle 11) $43,344
University of California, San Diego Cancer

Efficacy of the nicotine patch in adolescents & young adults 2002 (Cycle 11) $69,800
University of California, San Francisco Tobacco-Use Prevention and Cessation

Effect of cigarette smoke and nicotine on taste processing 2002 (Cycle 11) $70,000
University of California, Davis Nicotine Dependence

Total synthesis of cribrostatin 4, a potent anticancer agent 2002 (Cycle 11) $74,927
California Institute of Technology Cancer

Neuroadaptations underlying nicotine dependence 2002 (Cycle 11) $60,379
Scripps Research Institute Nicotine Dependence

Regulation of integrin activation by calcineurin 2002 (Cycle 11) $68,437
Scripps Research Institute Cardiovascular Disease

2001 (Cycle 10)
ZIP kinase and lung cancer 2001 (Cycle 10) $65,854
The Burnham Institute for Medical Research Cancer

PPARs in intestinal and colonic tumorigenesis 2001 (Cycle 10) $74,952
Salk Institute for Biological Studies Cancer

Neuronal nicotinic receptor trafficking in nicotine addiction 2001 (Cycle 10) $71,664
California Institute of Technology Nicotine Dependence

Functions of IRF-1 and Smad3 interaction in lung cancer 2001 (Cycle 10) $69,750
University of California, San Francisco Cancer

Nicotine dependence & schizophrenia 2001 (Cycle 10) $75,600
Scripps Research Institute Nicotine Dependence

Depression as a predictor of smoking treatment outcome 2001 (Cycle 10) $52,467
University of California, San Francisco Epidemiology

Molecular targets for tobacco oxidants in lung cell death 2001 (Cycle 10) $70,000
University of California, Davis Pulmonary Disease

Contributions of CNRs to nicotinic signaling 2001 (Cycle 10) $70,000
University of California, San Diego Nicotine Dependence

2000 (Cycle 9)
Transcriptional regulation in normal and neoplastic lung 2000 (Cycle 9) $69,350
University of California, San Diego Cancer

Thiol-aldehyde adducts and tobacco smoke toxicity 2000 (Cycle 9) $49,622
University of California, Davis Pulmonary Disease

Cell-cell interact reg distrib of nic receptrs on neurons 2000 (Cycle 9) $29,754
University of California, San Diego Nicotine Dependence

Mitotic spindle checkpoint & chromosomal instability 2000 (Cycle 9) $69,500
Ludwig Institute for Cancer Research General Biomedical Science

Siah-family proteins in lung cancer 2000 (Cycle 9) $74,560
The Burnham Institute for Medical Research Cancer

1999 (Cycle 8)
Importance of Rce1 and Ras in tobacco-induced cancers 1999 (Cycle 8) $75,209
J. David Gladstone Institutes Cancer

Effects of PSA content and formal features on smoking norms 1999 (Cycle 8) $44,284
Stanford University Public Health, Public Policy, and Economics

Effect of tobacco smoke on nitric oxide synthesis 1999 (Cycle 8) $70,000
University of California, Davis Cardiovascular Disease

Study of novel metastasis inhibitors in lung cancer 1999 (Cycle 8) $69,208
University of California, San Diego Cancer

Dynamics of state tobacco control making 1999 (Cycle 8) $70,000
University of California, San Francisco Public Health, Public Policy, and Economics

A model system for smoking-related damage to proteins 1999 (Cycle 8) $75,375
J. David Gladstone Institutes Cardiovascular Disease

Membrane proteins and TGF-alpha/EGFR: a role in lung cancer? 1999 (Cycle 8) $40,436
University of California, San Francisco Cancer

Oxidized lipids and programmed cell death in atherosclerosis 1999 (Cycle 8) $69,116
University of California, San Diego Cardiovascular Disease

The role of chloride in tobacco-smoke-induced cancer 1999 (Cycle 8) $30,580
University of California, San Francisco Cancer

1998 (Cycle 7)
BAG-1, a unique gene involved in smoking-associated cancers 1998 (Cycle 7) $75,060
The Burnham Institute for Medical Research Cancer

Functional significance of the protein CD40 in lung cancer 1998 (Cycle 7) $35,000
University of California, San Diego Cancer

How are beneficial cholesterol transport proteins produced? 1998 (Cycle 7) $37,069
J. David Gladstone Institutes Cardiovascular Disease

Dissecting signaling pathways to test cancer-killing agents 1998 (Cycle 7) $69,694
University of California, San Diego Cancer

Structural determinants of alpha-toxin: nAChR interactions 1998 (Cycle 7) $70,000
University of California, San Diego Nicotine Dependence

Boosting the immune response against lung cancer 1998 (Cycle 7) $70,000
University of California, Los Angeles Cancer

A study of Bax, a gene involved in killing tumor cells 1998 (Cycle 7) $75,060
The Burnham Institute for Medical Research Cancer

TGF-a: we need it, but too much is bad 1998 (Cycle 7) $69,967
University of California, San Francisco Cancer

The role of nitric oxide in nicot induced muscle cell death 1998 (Cycle 7) $68,011
The Parkinson's Institute Nicotine Dependence

1997 (Cycle 6)
Role of intracellular signals in tobacco-related disease 1997 (Cycle 6) $69,600
University of California, San Diego Cancer

A novel therapeutic target for stroke 1997 (Cycle 6) $72,310
The Burnham Institute for Medical Research Cardiovascular Disease

Current legal issues in tobacco 1997 (Cycle 6) $34,746
University of California, San Francisco Public Health, Public Policy, and Economics

Does nicotine alter intercellular communication pathways? 1997 (Cycle 6) $68,864
University of California, San Diego Cancer

Analysis of a nicotine-related receptor binding site 1997 (Cycle 6) $69,218
University of California, San Francisco Nicotine Dependence

1995 (Cycle 4)
Growth Factor Receptor Activation by Papillomavirus Proteins 1995 (Cycle 4) $63,439
University of California, San Diego Cancer

Function of Rb-interacting zinc-finger protein, "RIZ" 1995 (Cycle 4) $13,665
Sidney Kimmel Cancer Center Cancer

Proteolytic Maturation of Ras & Yeast a-Factor 1995 (Cycle 4) $65,000
University of California, Berkeley Cancer

Effects of Disturbed Flow on Endothelial Cell Function 1995 (Cycle 4) $52,345
University of California, Los Angeles Cardiovascular Disease

Physiology of Diastolic Dysfunction during Transient Ischemia 1995 (Cycle 4) $30,000
University of California, San Francisco Cardiovascular Disease

The Cellular Localization and Function of Cyclophilin B 1995 (Cycle 4) $60,775
University of California, San Diego General Biomedical Science

Function of Rb-interacting zinc-finger protein, "RIZ" 1995 (Cycle 4) $32,400
The Burnham Institute for Medical Research Cancer

Isolation of a Tumor Promoter Induced C-Fos Kinase 1995 (Cycle 4) $55,000
University of California, San Diego Cancer

Nicotine Interactions with Central Stress Circuitry 1995 (Cycle 4) $69,120
Salk Institute for Biological Studies Nicotine Dependence

Role in Associated Proteins in TGF-B Receptor Signalling 1995 (Cycle 4) $29,990
University of California, San Francisco Cancer

Regulation of Nicotinic Receptors on Neurons by Muscle 1995 (Cycle 4) $37,783
University of California, San Diego Nicotine Dependence

1994 (Cycle 3)
Protein Kinases: Unique Probes for the ATP Binding Site 1994 (Cycle 3) $69,411
University of California, San Diego General Biomedical Science

Molecular Mechanisms of Brain Nicotinic Receptor Inactivation 1994 (Cycle 3) $42,567
California Institute of Technology Nicotine Dependence

Signal Transduction by TGF-d Precursor During Transformation 1994 (Cycle 3) $69,110
University of California, San Francisco Cancer

MDMI a Gene Involved in Yeast Mitochondrial Inheritance 1994 (Cycle 3) $70,000
University of California, San Diego Cancer

DNA Damage in Germ & Somatic Cells of Smokers 1994 (Cycle 3) $70,000
University of California, Berkeley General Biomedical Science

Retinoid X Receptors in Oncogenesis 1994 (Cycle 3) $75,600
Salk Institute for Biological Studies Cancer

Isolation/Oncogene-activated cJun Kinase Linking Ras to AP-1 1994 (Cycle 3) $53,750
University of California, San Diego Cancer

The Mechanics and Regulation of Centromere Function 1994 (Cycle 3) $69,586
University of California, Santa Barbara General Biomedical Science

Cell Cycle Regulation of Proliferation Genes 1994 (Cycle 3) $32,400
California Institute of Technology Cancer

Self-Presentation: Adolescent Cigarette Effects 1994 (Cycle 3) $18,400
University of Southern California Public Health, Public Policy, and Economics

Biochemical and Functional Characterization of HIP-116 1994 (Cycle 3) $75,600
Salk Institute for Biological Studies General Biomedical Science

Tobacco Smoke Exposure-Induced Alt of Vasc Fibrinolytic Sys 1994 (Cycle 3) $30,469
University of California, San Diego Cardiovascular Disease

Regulation of the cJun protein by phosphorylation 1994 (Cycle 3) $70,000
University of California, San Diego General Biomedical Science

1993 (Cycle 2)
Nicotine-induced Changes in Gene Expression 1993 (Cycle 2) $70,000
University of California, San Diego Nicotine Dependence

Regulation of Tranformation by the Fos Gene 1993 (Cycle 2) $61,384
Salk Institute for Biological Studies General Biomedical Science

Assessment of Teen Tobacco Use by Primary Care Physicians 1993 (Cycle 2) $70,000
University of California, San Francisco Tobacco-Use Prevention and Cessation

Role of Yeast CDC7 Gene in Initiation of DNA Replicaton 1993 (Cycle 2) $44,906
California Institute of Technology General Biomedical Science

Post-Translational Processing of Ras and Yeast a-Factor 1993 (Cycle 2) $70,000
University of California, Berkeley General Biomedical Science

Regulation of CO2 Transport in Circulatory & Respiratory ... 1993 (Cycle 2) $75,600
LA Biomedical Research Institute at Harbor-UCLA Medical Center Cardiovascular Disease

Neuronal ACh Receptors: Candidates for Mediating Addiction 1993 (Cycle 2) $66,994
University of California, San Diego Nicotine Dependence

Homeobox Genes Hematopoiesis and Leukemogenesis 1993 (Cycle 2) $70,000
University of California, Los Angeles Cancer

Ras Prenylation, Cholesterol Biosynthesis and Lung Cancer 1993 (Cycle 2) $49,960
The Burnham Institute for Medical Research Cancer

Direct Effect of Nicotine on the Early Outward K Channel 1993 (Cycle 2) $75,588
Northern California Institute for Research & Education Pulmonary Disease

Probing the Nucleotide Binding Site of Protein Kinases 1993 (Cycle 2) $41,146
University of California, San Diego General Biomedical Science

Mechanisms of Thrombin/Receptor Interaction 1993 (Cycle 2) $68,817
University of California, San Francisco Cardiovascular Disease

Involvement of RAS and Krev-1 in Lung Cancer 1993 (Cycle 2) $50,552
The Burnham Institute for Medical Research Cancer

Nicotine, Paraventricular Nuclei and Corticosteroids 1993 (Cycle 2) $58,408
University of California, San Francisco General Biomedical Science

Protein Prenyltransferases Required for Ras Function 1993 (Cycle 2) $70,000
University of California, Berkeley General Biomedical Science

1992 (Cycle 1)
Acute & Chronic Effects of Tobacco & Non-tobacco Smoking 1992 (Cycle 1) $27,491
University of California, Los Angeles Pulmonary Disease

Molecular Mechanism of Retinoic Acid Action 1992 (Cycle 1) $75,600
The Burnham Institute for Medical Research General Biomedical Science

Molecular Studies of NNK-Induced Lung Tumors in Hamsters 1992 (Cycle 1) $35,000
University of California, Davis Cancer

Role of Jun Family of Proto-Oncogenes in Lung Cancer 1992 (Cycle 1) $68,400
University of California, San Diego Cancer

Lung Reflexes & Afferent Properties in Health and Disease 1992 (Cycle 1) $70,000
University of California, Davis Pulmonary Disease

Nicotine Effects on Enodthelial Cell Growth & Function 1992 (Cycle 1) $69,038
University of California, Davis Cardiovascular Disease

Effects of Cigarette Smoke in Rat Pulmonary Arteries 1992 (Cycle 1) $68,650
University of California, San Diego Pulmonary Disease

Drug Resistance During Induction Chemotherapy for Lung Cancer 1992 (Cycle 1) $31,874
Stanford University Cancer

Glutathione Transferase in Lung Cancer: Transfection Studies 1992 (Cycle 1) $67,732
Stanford University Cancer

Influence of Cigarette Smoke on Neurogenic Inflammation 1992 (Cycle 1) $57,180
University of California, San Francisco General Biomedical Science

Endothelial Barrier Injury by Tobacco Smoke 1992 (Cycle 1) $60,945
University of California, Davis Cardiovascular Disease

Smoking & Lipoprotein-Based Mechanisms of Atherogenesis 1992 (Cycle 1) $69,999
University of California, San Francisco Cardiovascular Disease

Pulmonary Epithelial Injury by Tobacco Smoke in Vitro 1992 (Cycle 1) $70,616
University of California, Davis Pulmonary Disease

Effects of Cigarettes & Carbon Monixide in Exercise in COP 1992 (Cycle 1) $75,247
LA Biomedical Research Institute at Harbor-UCLA Medical Center Pulmonary Disease

Molecular Dynamics of Acetylcholinesterase Mutants 1992 (Cycle 1) $70,000
University of California, San Diego Nicotine Dependence

Acute & Chronic Nicotine Treatment on Gastric Ulceration 1992 (Cycle 1) $70,000
University of California, Los Angeles General Biomedical Science

Leukotriene A4 Hydrolase Secretion by Airway Epithelia 1992 (Cycle 1) $70,156
University of California, San Diego Pulmonary Disease

Health Services Research 1992 (Cycle 1) $53,118
University of California, San Francisco Public Health, Public Policy, and Economics

Analysis of RAS Mutations in the Canine Smoking Model 1992 (Cycle 1) $70,000
University of California, Davis Cancer

Cigarette Smoking Alterations in Thrombolytic Parameters 1992 (Cycle 1) $70,000
University of California, San Diego Cardiovascular Disease

IL-1 & PDGF: mRNA & Protein in Prodution by Alveolar Macro 1992 (Cycle 1) $56,204
University of California, San Diego Pulmonary Disease